We were honored to be able to speak about the promise of immuno-oncology (IO) therapeutics at this year’s Molecular Med Tri-Con conference and the 12th Annual Biomarkers Congress.
By Dr. Mark Roskey and Dr. David Duffy
By Kevin Hrusovsky, CEO and Executive Chairman at Quanterix
It’s time we truly take control of a disease that’s killing 1,500 Americans every single day. Cancer is the second leading cause of death in developed nations and one of the most feared in the United States. That's why detecting disease symptoms BEFORE they're present is critical.